Fit for future growth
Going forward, we see excellent growth opportunities for MM driven by the dynamic underlying market growth in segments like weight-loss drugs, oncology and medical devices. To support this growth, we invested more than EUR 100 million into machinery and infrastructure in the pharma business along with substantial investments to strengthen the teams across all areas. We are therefore well positioned to solidify our position as a leader in secondary pharma packaging in Europe and North America.